Development and validation of the Proxy-Reported Pulmonary Outcomes Scale for premature infants

Wayne A Price1, Sofia R Aliaga1, Sara E Massie2

  • 1Department of Pediatrics, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Insights

The Proxy-Reported Pulmonary Outcome Scale (PRPOS) is a feasible bedside tool for nurses to assess bronchopulmonary dysplasia (BPD) severity in preterm infants using functional measures. It shows internal consistency and validity in initial testing.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Clinical Assessment Tools

Background:

  • Bronchopulmonary dysplasia (BPD) is a significant complication in preterm infants.
  • Accurate assessment of BPD severity is crucial for appropriate management and outcomes.
  • Existing assessment tools may not fully capture functional respiratory status from a bedside perspective.

Purpose of the Study:

  • To evaluate the feasibility of the Proxy-Reported Pulmonary Outcome Scale (PRPOS) as a bedside nurse-reported tool.
  • To assess the PRPOS's ability to measure the severity of bronchopulmonary dysplasia (BPD) using functional, disease-related indicators.
  • To identify the most reliable items for a final PRPOS measurement tool.

Main Methods:

  • A 26-item instrument, the PRPOS, was tested by bedside nurses on preterm infants (born 23-30 weeks gestation).
  • Assessments were conducted at 36 to 37(4/7) weeks postmenstrual age, before, during, and after care times.
  • Item reliability, validity, and model fit were analyzed to select six final items.

Main Results:

  • Assessments were completed on 188 preterm infants.
  • PRPOS item scores increased with higher National Institute of Child Health and Development (NICHD) BPD categories.
  • The final six-item scale demonstrated internal consistency and known-groups validity.
  • PRPOS scores correlated with postmenstrual age at discharge and were higher in infants discharged on oxygen or diuretics.

Conclusions:

  • The PRPOS is an internally consistent, proxy-reported measure of respiratory function in premature infants.
  • It utilizes observable, functional performance measures for assessing BPD.
  • Initial testing supports its known-groups validity, with ongoing research to assess predictive validity.
Abstract

Related Concept Videos

Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
1.1K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
709